We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.2B
AUM Growth
+$2.41B
Cap. Flow
-$59.6M
Cap. Flow %
-0.17%
Top 10 Hldgs %
26.19%
Holding
2,465
New
206
Increased
1,202
Reduced
956
Closed
98

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$31.6M
2
PETS icon
PetMed Express
PETS
+$29.7M
3
ALB icon
Albemarle
ALB
+$27.7M
4
WMT icon
Walmart Inc
WMT
+$27.2M
5
NEE icon
NextEra Energy
NEE
+$27M

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 14.5%
3 Communication Services 10.43%
4 Healthcare 10.27%
5 Financials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRD
2276
DELISTED
RR Donnelley & Sons Co.
RRD
$115K ﹤0.01%
+18,383
New +$100K
ABUS icon
2277
Arbutus Biopharma
ABUS
$865M
$114K ﹤0.01%
37,580
+25,830
+220% +$80K
AXTI icon
2278
AXT Inc
AXTI
$3.09B
$114K ﹤0.01%
10,360
-189
-2% -$2.01K
ALTO icon
2279
Alto Ingredients
ALTO
$360M
$113K ﹤0.01%
+18,554
New +$108K
BW icon
2280
Babcock & Wilcox
BW
$1.43B
$113K ﹤0.01%
+14,401
New +$119K
CPLG
2281
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$109K ﹤0.01%
10,208
-285
-3% -$2.86K
ARAY icon
2282
Accuray
ARAY
$28.4M
$108K ﹤0.01%
23,999
-552
-2% -$2.58K
IMDX
2283
Insight Molecular Diagnostics
IMDX
$153M
$106K ﹤0.01%
919
-33
-3% -$3.22K
VKTX icon
2284
Viking Therapeutics
VKTX
$4.04B
$106K ﹤0.01%
17,747
+223
+1% +$1.32K
AWH
2285
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$106K ﹤0.01%
1,257
-260
-17% -$22.3K
ACIU icon
2286
AC Immune
ACIU
$227M
$104K ﹤0.01%
+13,053
New +$90.2K
ADAP
2287
DELISTED
Adaptimmune Therapeutics
ADAP
$104K ﹤0.01%
24,520
+5,680
+30% +$27.6K
BCEL
2288
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$104K ﹤0.01%
12,161
+298
+3% +$3.05K
CTXR icon
2289
Citius Pharmaceuticals
CTXR
$14.3M
$103K ﹤0.01%
+1,178
New +$70.8K
EVC icon
2290
Entravision Communication
EVC
$983M
$103K ﹤0.01%
15,413
-304
-2% -$1.37K
GSKY
2291
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$103K ﹤0.01%
18,618
+1,740
+10% +$10.4K
EGIO
2292
DELISTED
Edgio, Inc. Common Stock
EGIO
$102K ﹤0.01%
811
+7
+0.9% +$924
QMCO icon
2293
Quantum Corp
QMCO
$437M
$100K ﹤0.01%
725
+169
+30% +$27.3K
ZIXI
2294
DELISTED
Zix Corporation
ZIXI
$98K ﹤0.01%
13,882
-719
-5% -$5.21K
KODK icon
2295
Kodak
KODK
$806M
$97K ﹤0.01%
+11,641
New +$91.4K
DRRX
2296
DELISTED
DURECT Corp
DRRX
$96K ﹤0.01%
5,869
-90
-2% -$1.57K
GRTS
2297
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$96K ﹤0.01%
+10,476
New +$96.9K
KZR
2298
DELISTED
Kezar Life Sciences
KZR
$95K ﹤0.01%
1,752
+275
+19% +$15.6K
RES icon
2299
RPC Inc
RES
$1.24B
$95K ﹤0.01%
19,111
+2,033
+12% +$11K
STGW icon
2300
Stagwell
STGW
$1.84B
$95K ﹤0.01%
+16,215
New +$75.7K

Similar funds

ProShare Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, ProShare Advisors held 2,465 positions worth $34.2B, up 7.6% from $31.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors's Q2 2021 filing shows 206 new, 1,202 increased, 956 reduced and 98 closed positions. Its largest new stake was Trinity Industries: 371,743 shares worth $10M. The largest sale was Amazon, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q2 2021 buy was Trinity Industries: 371,743 shares worth $10M.
  • ProShare Advisors added most to Johnson & Johnson in Q2 2021, an estimated $31.6M increase.
  • ProShare Advisors's biggest Q2 2021 reduction was Amazon, cutting an estimated $155M.
  • ProShare Advisors fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $60.1M.
  • ProShare Advisors's ten largest holdings make up 26% of its $34.2B portfolio in Q2 2021.
  • ProShare Advisors opened 206 new positions and closed 98 in Q2 2021.
  • ProShare Advisors's portfolio value rose 7.6% quarter-over-quarter to $34.2B.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.